• Sun Pharma gives commercialisation license to CMS for seven products expresspharma
    August 21, 2019
    Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has granted an exclusive license to a subsidiary of China Medical System Holdings (CMS) to develop and commercialise seven generic products in Mainland China.
PharmaSources Customer Service